Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 81

Sort by

Sort Order Select

Journal Articles

Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis

Richard T. Piszczatowski, Hannes E. Bülow, Ulrich Steidl

Blood (2024) 143 (25): 2571–2587.

https://doi.org/10.1182/blood.2023022736

Published: 2024

Journal Articles

Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age

Ioannis Mantzaris, Mendel Goldfinger, Nishi Shah, Annemarie Munoz, Aradhika Dhawan, Nicole Chambers, Karen Fehn, Joel Victor, Aditi Shastri, Kira Gritsman, Noah Kornblum, Alejandro Sica, Dennis L Cooper, Amit Verma, Mimi Kim, Ulrich Steidl, Eric J Feldman, Marina Y. Konopleva

Blood (2023) 142 (Supplement 1): 4257.

https://doi.org/10.1182/blood-2023-188176

Published: 2023

Journal Articles

GDF11/SMAD Regulated Splicing of GATA1 Is Associated with Response to Luspatercept in Lower-Risk Myelodysplastic Syndromes (LR-MDS)

Blood (2023) 142 (Supplement 1): 318.

https://doi.org/10.1182/blood-2023-179131

Published: 2023

Journal Articles

Novel Clinically Useful Inhibitor of Mediator Complex, RVU120, Relives Differentiation Block in MDS/AML

Blood (2023) 142 (Supplement 1): 3225.

https://doi.org/10.1182/blood-2023-186227

Published: 2023

Journal Articles

The Dual Inflammasome/Myddosome Inhibitor HT-6184 Restores Erythropoiesis in MDS/AML

Blood (2023) 142 (Supplement 1): 1417.

https://doi.org/10.1182/blood-2023-182289

Published: 2023

Journal Articles

Hematopoietic Stem Cell Numbers Are Regulated at Both Systemic and Local Levels

Shoichiro Takeishi, Tony Marchand, Wade R. Koba, Daniel K. Borger, Chunliang Xu, Chandan Guha, Aviv Bergman, Paul S. Frenette, Kira Gritsman, Ulrich Steidl

Blood (2023) 142 (Supplement 1): 511.

https://doi.org/10.1182/blood-2023-174407

Published: 2023

Journal Articles

Transcription Factor Redistributors Pharmacologically Actuate Non-Canonical Gene Networks to Drive AML Differentiation

Samuel Taylor, Jacob Stauber, Oliver Bohorquez, Emily Schwenger, Sriram Sundaravel, Abdelbasset Farahat, Boris Bartholdy, David Boykin, Gregory Poon, Ulrich Steidl

Blood (2023) 142 (Supplement 1): 119.

https://doi.org/10.1182/blood-2023-186698

Published: 2023

Journal Articles

Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling Inhibition

Blood (2022) 140 (Supplement 1): 3480–3482.

https://doi.org/10.1182/blood-2022-169102

Published: 2022

Journal Articles

Outcomes Analysis of T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (T-ALL/T-LBL) in a Minority Rich Cohort

Blood (2022) 140 (Supplement 1): 11595–11597.

https://doi.org/10.1182/blood-2022-159826

Published: 2022

Journal Articles

Allogeneic but Not Autologous Stem Cell Transplantation Improves Outcome in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

Blood (2022) 140 (Supplement 1): 662–664.

https://doi.org/10.1182/blood-2022-170332

Published: 2022

Journal Articles

Posttranscriptional Arid3a deregulation in AMKL

Justin C. Wheat, Ulrich Steidl

Blood (2022) 139 (5): 637–638.

https://doi.org/10.1182/blood.2021014081

Published: 2022

Journal Articles

Transcriptional circuit dynamics in HSPCs

Goichi Tatsumi, Ulrich Steidl

Blood (2021) 138 (16): 1382–1384.

https://doi.org/10.1182/blood.2021012452

Published: 2021

Journal Articles

Gene expression at a single-molecule level: implications for myelodysplastic syndromes and acute myeloid leukemia

Justin C. Wheat, Ulrich Steidl

Blood (2021) 138 (8): 625–636.

https://doi.org/10.1182/blood.2019004261

Published: 2021

Journal Articles

Preleukemic and leukemic evolution at the stem cell level

Jacob Stauber, John M. Greally, Ulrich Steidl

Blood (2021) 137 (8): 1013–1018.

https://doi.org/10.1182/blood.2019004397

Published: 2021

Journal Articles

LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML

Monica Cusan, Sheng F. Cai, Helai P. Mohammad, Andrei Krivtsov, Alan Chramiec, Evangelia Loizou, Matthew D. Witkin, Kimberly N. Smitheman, Daniel G. Tenen, Min Ye, Britta Will, Ulrich Steidl, Ryan G. Kruger, Ross L. Levine, Hugh Y. Rienhoff, Jr, Richard P. Koche, Scott A. Armstrong

Blood (2018) 131 (15): 1730–1742.

https://doi.org/10.1182/blood-2017-09-807024

Published: 2018

Includes: Supplemental data

Journal Articles

Metabolic strugGLS after FLT3 inhibition in AML

Samuel J. Taylor, Ulrich Steidl

Blood (2018) 131 (15): 1631–1632.

https://doi.org/10.1182/blood-2018-03-836338

Published: 2018

Journal Articles

Stem and progenitor cell alterations in myelodysplastic syndromes

Aditi Shastri, Britta Will, Ulrich Steidl, Amit Verma

Blood (2017) 129 (12): 1586–1594.

https://doi.org/10.1182/blood-2016-10-696062

Published: 2017

Journal Articles

Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3

Blood (2016) 128 (22): 4314.

https://doi.org/10.1182/blood.V128.22.4314.4314

Published: 2016

Journal Articles

Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS -Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109

Kira Gritsman, MD PhD, Robert P. Hasserjian, MD, Taneisha Sinclair, David M. Weinstock, MD, Britta Will, PhD, Ulrich Steidl, MD PhD, Karen K. Ballen, MD, Amir T. Fathi, MD, Amit Verma, MD, Dejan Juric, MD, Philip C. Amrein, MD

Blood (2016) 128 (22): 2749.

https://doi.org/10.1182/blood.V128.22.2749.2749

Published: 2016

Journal Articles

Hispanic Ethnicity Is Associated with Younger Age at Presentation and Worse Survival in AML

Karine Antonovna Darbinyan, MD, Daniel Helbig, MDcal Student, Junaid Saleh Esa, College student, Anjali Budhathoki, MD, Swati Goel, MD, Aditi Shastri, MD, Murali Janakiram, MD, Noah Kornblum, MD, Olga Derman, MD, Kira Gritsman, MD PhD, Ulrich Steidl, MD PhD, Amit Verma, MD, Ira Braunschweig, MD, Ioannis Mantzaris, MD

Blood (2016) 128 (22): 3600.

https://doi.org/10.1182/blood.V128.22.3600.3600

Published: 2016

NARROW

Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis

Venetoclax Combined with “7+3” Induction Chemotherapy Induces High Rates of MRD-Negative Remission in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Irrespective of Age

GDF11/SMAD Regulated Splicing of GATA1 Is Associated with Response to Luspatercept in Lower-Risk Myelodysplastic Syndromes (LR-MDS)

Novel Clinically Useful Inhibitor of Mediator Complex, RVU120, Relives Differentiation Block in MDS/AML

The Dual Inflammasome/Myddosome Inhibitor HT-6184 Restores Erythropoiesis in MDS/AML

Hematopoietic Stem Cell Numbers Are Regulated at Both Systemic and Local Levels

Transcription Factor Redistributors Pharmacologically Actuate Non-Canonical Gene Networks to Drive AML Differentiation

Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling Inhibition

Outcomes Analysis of T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma (T-ALL/T-LBL) in a Minority Rich Cohort

Allogeneic but Not Autologous Stem Cell Transplantation Improves Outcome in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma

Posttranscriptional Arid3a deregulation in AMKL

Transcriptional circuit dynamics in HSPCs

Gene expression at a single-molecule level: implications for myelodysplastic syndromes and acute myeloid leukemia

Preleukemic and leukemic evolution at the stem cell level

LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML

Metabolic strugGLS after FLT3 inhibition in AML

Stem and progenitor cell alterations in myelodysplastic syndromes

Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3

Examination of Phosphoprotein Targets in Timed Samples from Patients with RAS -Mutated AML during Concurrent Treatment with Alpelisib and Binimetinib on the Phase Ib Clinical Trial CMEK162X2109

Hispanic Ethnicity Is Associated with Younger Age at Presentation and Worse Survival in AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only